Hui-Wen Lue, Ph.D.
Affiliations: | 2012 | Georgia State University, Atlanta, GA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Hui-Wen Lue"Parents
Sign in to add mentorZhi-ren Liu | grad student | 2012 | Georgia State | |
(LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gao B, Lue HW, Podolak J, et al. (2019) Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma. Metabolites. 9 |
Lue HW, Podolak J, Kolahi K, et al. (2017) Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade. Genes & Development |
Podolak J, Eilers K, Newby T, et al. (2017) Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer. Oncotarget. 8: 71447-71455 |
Podolak J, Eilers K, Newby T, et al. (2017) Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer. Oncotarget |
Lue HW, Cole B, Rao SA, et al. (2015) Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma. Oncotarget |
Lue HW, Yang X, Wang R, et al. (2011) LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. Plos One. 6: e27720 |
Huang WC, Havel JJ, Zhau HE, et al. (2008) Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5341-7 |
Zhau HE, Odero-Marah V, Lue HW, et al. (2008) Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clinical & Experimental Metastasis. 25: 601-10 |
Arnold RS, Chung LW, Farach-Carson MC, et al. (2008) PROSTATE CANCER BONE METASTASIS: REACTIVE OXYGEN SPECIES, GROWTH FACTORS AND HEPARAN SULFATE PROTEOGLYCANS PROVIDE A SIGNALING TRIAD THAT SUPPORTS PROGRESSION Journal of Urology. 179: 192-192 |